{"id":"https://openalex.org/W2034301751","doi":"https://doi.org/10.1016/s0143-4179(98)90048-8","title":"Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan","display_name":"Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan","publication_year":1998,"publication_date":"1998-06-01","ids":{"openalex":"https://openalex.org/W2034301751","doi":"https://doi.org/10.1016/s0143-4179(98)90048-8","mag":"2034301751","pmid":"https://pubmed.ncbi.nlm.nih.gov/10189063"},"language":"en","primary_location":{"id":"doi:10.1016/s0143-4179(98)90048-8","doi":"https://doi.org/10.1016/s0143-4179(98)90048-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0143-4179(98)90048-8","pdf_url":null,"source":{"id":"https://openalex.org/S86238769","display_name":"Neuropeptides","issn_l":"0143-4179","issn":["0143-4179","1532-2785"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113593243","display_name":"V. Raghavendra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51452335","display_name":"Panjab University","ror":"https://ror.org/04p2sbk06","country_code":"IN","type":"education","lineage":["https://openalex.org/I51452335"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"V Raghavendra","raw_affiliation_strings":["Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India","institution_ids":["https://openalex.org/I51452335"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034354976","display_name":"Kanwaljit Chopra","orcid":"https://orcid.org/0000-0001-5898-6093","observed_orcids":["https://orcid.org/0000-0001-5898-6093"]},"institutions":[{"id":"https://openalex.org/I51452335","display_name":"Panjab University","ror":"https://ror.org/04p2sbk06","country_code":"IN","type":"education","lineage":["https://openalex.org/I51452335"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"K Chopra","raw_affiliation_strings":["Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India","institution_ids":["https://openalex.org/I51452335"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101824649","display_name":"Sachin Kulkarni","orcid":"https://orcid.org/0000-0002-4227-5390","observed_orcids":["https://orcid.org/0000-0002-4227-5390"]},"institutions":[{"id":"https://openalex.org/I51452335","display_name":"Panjab University","ror":"https://ror.org/04p2sbk06","country_code":"IN","type":"education","lineage":["https://openalex.org/I51452335"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"S.K Kulkarni","raw_affiliation_strings":["Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Division, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India","institution_ids":["https://openalex.org/I51452335"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101824649"],"corresponding_institution_ids":["https://openalex.org/I51452335"],"apc_list":{"value":3530,"currency":"USD","value_usd":3530},"apc_paid":null,"fwci":1.0004,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.77573437,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"32","issue":"3","first_page":"275","last_page":"280"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6395999789237976,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6395999789237976,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.33889999985694885,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":1.0},{"id":"https://openalex.org/keywords/at1-receptor-antagonists","display_name":"AT1 receptor antagonists","score":0.9459999799728394},{"id":"https://openalex.org/keywords/dopaminergic-system","display_name":"dopaminergic system","score":0.8700000047683716},{"id":"https://openalex.org/keywords/brain-renin-angiotensin-system","display_name":"brain renin-angiotensin system","score":0.9670000076293945},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.9319999814033508},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dopamine-release","display_name":"dopamine release","score":0.9779999852180481},{"id":"https://openalex.org/keywords/compensatory-mechanisms","display_name":"compensatory mechanisms","score":0.7749999761581421},{"id":"https://openalex.org/keywords/motor-function","display_name":"motor function","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.8432872295379639},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.8162058591842651},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.7944316864013672},{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.714139461517334},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.603305459022522},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6029961705207825},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5994420647621155},{"id":"https://openalex.org/C2779459141","wikidata":"https://www.wikidata.org/wiki/Q1198115","display_name":"Stereotypy","level":4,"score":0.5665972828865051},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5167083740234375},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4686920642852783},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.46456873416900635},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.44043588638305664},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4337179660797119},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.43222230672836304},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.35205256938934326},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.31731948256492615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27716967463493347},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.09861156344413757},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.04390740394592285}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001058","descriptor_name":"Apomorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002375","descriptor_name":"Catalepsy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D044139","descriptor_name":"Receptor, Angiotensin, Type 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044140","descriptor_name":"Receptor, Angiotensin, Type 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0143-4179(98)90048-8","doi":"https://doi.org/10.1016/s0143-4179(98)90048-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0143-4179(98)90048-8","pdf_url":null,"source":{"id":"https://openalex.org/S86238769","display_name":"Neuropeptides","issn_l":"0143-4179","issn":["0143-4179","1532-2785"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"journal-article"},{"id":"pmid:10189063","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10189063","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1481976521","https://openalex.org/W1508825618","https://openalex.org/W1967612660","https://openalex.org/W1968168761","https://openalex.org/W1976760386","https://openalex.org/W1979219161","https://openalex.org/W1979972698","https://openalex.org/W1990624382","https://openalex.org/W1991808350","https://openalex.org/W1993052853","https://openalex.org/W2007320512","https://openalex.org/W2009447429","https://openalex.org/W2010544476","https://openalex.org/W2011362026","https://openalex.org/W2012929843","https://openalex.org/W2017452805","https://openalex.org/W2018484090","https://openalex.org/W2023574451","https://openalex.org/W2025914427","https://openalex.org/W2029198174","https://openalex.org/W2038232427","https://openalex.org/W2042592058","https://openalex.org/W2044814048","https://openalex.org/W2056711405","https://openalex.org/W2061624095","https://openalex.org/W2061898251","https://openalex.org/W2063349406","https://openalex.org/W2076624053","https://openalex.org/W2082890430","https://openalex.org/W2083530994","https://openalex.org/W2083677489","https://openalex.org/W2084385368","https://openalex.org/W2155280732","https://openalex.org/W2173507839","https://openalex.org/W2340994737","https://openalex.org/W2411915378","https://openalex.org/W2419568116","https://openalex.org/W2770299037","https://openalex.org/W6628847040"],"related_works":["https://openalex.org/W2223361405","https://openalex.org/W2079995888","https://openalex.org/W2116490811","https://openalex.org/W2005623285","https://openalex.org/W2044814048","https://openalex.org/W2085265114","https://openalex.org/W2020777954","https://openalex.org/W2047194297","https://openalex.org/W4245045608","https://openalex.org/W2293240547"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}